Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-029243
Filing Date
2025-02-27
Accepted
2025-02-27 17:20:30
Documents
80
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K etnb-20241231.htm   iXBRL 10-K 3140179
2 EX-19.1 etnb-ex19_1.htm EX-19.1 121713
3 EX-23.1 etnb-ex23_1.htm EX-23.1 2835
4 EX-31.1 etnb-ex31_1.htm EX-31.1 17085
5 EX-31.2 etnb-ex31_2.htm EX-31.2 17097
6 EX-32.1 etnb-ex32_1.htm EX-32.1 14404
7 GRAPHIC img33955113_0.jpg GRAPHIC 679318
8 GRAPHIC img33955113_1.jpg GRAPHIC 793484
9 GRAPHIC img33955113_2.jpg GRAPHIC 554317
10 GRAPHIC img33955113_3.jpg GRAPHIC 162683
  Complete submission text file 0000950170-25-029243.txt   17726198

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT etnb-20241231.xsd EX-101.SCH 1626290
83 EXTRACTED XBRL INSTANCE DOCUMENT etnb-20241231_htm.xml XML 2294186
Mailing Address 655 MONTGOMERY STREET SUITE 1500 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 1500 SAN FRANCISCO CA 94111 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39122 | Film No.: 25680754
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)